feed,title,long_url,short_url
Benzinga,ResMed's Q4 Results: Analysts Say Uncertain Market Dynamics Follow Amid Philips Re-Entry,https://benzinga.com/analyst-ratings/analyst-color/23/08/33578061/resmeds-q4-results-analysts-say-uncertain-market-dynamics-follow-amid-philips-re-en,https://da.gd/Qgp6MD
Benzinga,P/E Ratio Insights for Johnson & Johnson,https://benzinga.com/news/23/08/33579873/pe-ratio-insights-for-johnson-johnson,https://da.gd/lfTq8
